Position in CELC
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$21,914,765
+$7,731,438 QoQ
Shares Held
191,999
+35.0% QoQ
Ownership
0.394%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $2,945,771,612 across 414 Biotechnology names. CELC ranks #31 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
448,371 | $346,429,369 | |
| 2 | MRNA |
Moderna, Inc.
|
4,317,219 | $219,314,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
415,625 | $185,593,187 | |
| 4 | BNTX |
BioNTech SE
|
1,651,789 | $146,811,006 | |
| 5 | ARGX |
Argenx SE
|
177,836 | $129,864,739 | |
| 6 | INSM |
INSMED Inc
|
604,600 | $98,864,192 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,307,176 | $97,070,889 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
280,965 | $92,962,889 |
All Filings in CELC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,914,765 | 191,999 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $14,183,327 | 142,203 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $8,835,239 | 178,851 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $35,337 | 2,647 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,962 | 1,480 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $43,524 | 3,325 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $672,590 | 45,110 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $33,841 | 2,066 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $193,039 | 8,937 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $72,951 | 5,007 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $23,572 | 2,579 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $49,717 | 4,528 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $461 | 45 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,106 | 79 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,566 | 156 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $8,326 | 915 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,386 | 897 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $28,002 | 2,123 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $33,012 | 1,834 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $8,712 | 363 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $1,778 | 124 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $1,135 | 124 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,769 | 305 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $13,478 | 1,945 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $11,895 | 1,830 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||